Affordable Access

[Role of abdominal obesity in pathogenesis of insulin resistance syndrome].

Authors
  • Almazov, V A
  • Blagosklonnaia, Ia V
  • Shliakhto, E V
  • Krasil'nikova, E I
Type
Published Article
Journal
Terapevticheskiĭ arkhiv
Publication Date
Jan 01, 1999
Volume
71
Issue
10
Pages
18–22
Identifiers
PMID: 10612167
Source
Medline
License
Unknown

Abstract

Abdominal obesity is the earliest symptom in composition of metabolic cardiovascular syndrome. Prevention or early treatment of this obesity can prevent or delay onset of diseases associated with this syndrome.

Report this publication

Statistics

Seen <100 times